Soligenix, Inc: Soligenix On Track to Deliver Important Front-Line Treatment to US Market in 2024
Company Seeks Approval for Reverse Stock Split to Maintain Nasdaq ListingNEW YORK, NY, Jan 16, 2023 - (ACN Newswire) - PCG Digital -- Soligenix, Inc. (Nasdaq: SNGX), a late-stage biopharmaceutical company
Source: finanznachrichten.de